Use of anti-eotaxin antibodies for treating inflammatory bowel disease

• 收藏
• 分享

专利权人:

Daniel Teper;Immune Pharmaceuticals Ltd.

发明人:

Teper, Daniel

申请号：

AU2014229137

公开号：

AU2014229137A1

申请日:

2014.03.13

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention provides use of one or more complementary determining regions (CDRs) of the CAT-212-213 VH and/or VL domains in non-native antibody framework regions, or, alternatively, the whole VH, VL, CAT-212 or CAT-213 antibody, in treating an inflammatory disease in a subject, such as an inflammatory bowel disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/